Optos is a leading medical technology company for the design, development, manufacturing and marketing of ultra-widefield retinal imaging devices.
Ultra-widefield retinal imaging is an important tool for the screening and diagnosis of eye problems, such as retinal detachment, glaucoma, cataracts, retinal holes/retinal tears and age-related macular degeneration, it can also indicate evidence of non-eye diseases, such as diabetes, hypertension and certain cancers.
Optos news releases are listed in chronological order and are archived by year. The archives contain news on local events, local press, and product news.
Read Press Releases
View the latest interim reports, interim statements, trading updates, and company news. News listings are listed in chronological order and are archived by year.
Read Regulatory News
You may download several high-resolution images and logos that may be used in articles about Optos. By downloading and using any of the Optos product images, you acknowledge that you understand and agree to the following Image Usage Agreement and the Logo Usage Guidelines.
Should you require additional imagery please contact email@example.com.
Download images and logo
Quote delayed 20 minutes
Share price information
Sign up for email notifications
16 - May - 2013Interim Results Announcement for the six months ended 31 March 2013
Optos plcQueensferry HouseCarnegie CampusEnterprise WayDunfermlineScotland KY11 8GRUK
+44 (0) 1383 843 300+44 (0) 1383 843 337
© 2013 Optos. All rights reserved. Optos®, optos® and optomap® are registered trademarks of Optos plc.
Accessibility Statement |
Terms and Conditions |
Registered in Scotland |
Distributors Login |